Literature DB >> 25516464

Does microbiota composition affect thyroid homeostasis?

Camilla Virili1, Marco Centanni.   

Abstract

The intestinal microbiota is essential for the host to ensure digestive and immunologic homeostasis. When microbiota homeostasis is impaired and dysbiosis occurs, the malfunction of epithelial barrier leads to intestinal and systemic disorders, chiefly immunologic and metabolic. The role of the intestinal tract is crucial in the metabolism of nutrients, drugs, and hormones, including exogenous and endogenous iodothyronines as well as micronutrients involved in thyroid homeostasis. However, the link between thyroid homeostasis and microbiota composition is not yet completely ascertained. A pathogenetic link with dysbiosis has been described in different autoimmune disorders but not yet fully elucidated in autoimmune thyroid disease which represents the most frequent of them. Anyway, it has been suggested that intestinal dysbiosis may trigger autoimmune thyroiditis. Furthermore, hypo- and hyper-thyroidism, often of autoimmune origin, were respectively associated to small intestinal bacterial overgrowth and to changes in microbiota composition. Whether some steps of this thyroid network may be affected by intestinal microbiota composition is briefly discussed below.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25516464     DOI: 10.1007/s12020-014-0509-2

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  43 in total

Review 1.  Gut microbiota and its pathophysiology in disease paradigms.

Authors:  Davide Festi; Ramona Schiumerini; Chiara Birtolo; Luca Marzi; Lucia Montrone; Eleonora Scaioli; Anna Rita Di Biase; Antonio Colecchia
Journal:  Dig Dis       Date:  2011-12-12       Impact factor: 2.404

Review 2.  Activation and inactivation of thyroid hormone by deiodinases: local action with general consequences.

Authors:  B Gereben; A Zeöld; M Dentice; D Salvatore; A C Bianco
Journal:  Cell Mol Life Sci       Date:  2008-02       Impact factor: 9.261

Review 3.  Hydrolysis of iodothyronine conjugates by intestinal bacteria.

Authors:  M P Hazenberg; W W de Herder; T J Visser
Journal:  FEMS Microbiol Rev       Date:  1988-02       Impact factor: 16.408

4.  Thyroxine treatment: absorption, malabsorption, and novel therapeutic approaches.

Authors:  Marco Centanni
Journal:  Endocrine       Date:  2012-10-25       Impact factor: 3.633

Review 5.  Alternate pathways of thyroid hormone metabolism.

Authors:  Sing-Yung Wu; William L Green; Wen-Sheng Huang; Marguerite T Hays; Inder J Chopra
Journal:  Thyroid       Date:  2005-08       Impact factor: 6.568

6.  Enterotypes of the human gut microbiome.

Authors:  Manimozhiyan Arumugam; Jeroen Raes; Eric Pelletier; Denis Le Paslier; Takuji Yamada; Daniel R Mende; Gabriel R Fernandes; Julien Tap; Thomas Bruls; Jean-Michel Batto; Marcelo Bertalan; Natalia Borruel; Francesc Casellas; Leyden Fernandez; Laurent Gautier; Torben Hansen; Masahira Hattori; Tetsuya Hayashi; Michiel Kleerebezem; Ken Kurokawa; Marion Leclerc; Florence Levenez; Chaysavanh Manichanh; H Bjørn Nielsen; Trine Nielsen; Nicolas Pons; Julie Poulain; Junjie Qin; Thomas Sicheritz-Ponten; Sebastian Tims; David Torrents; Edgardo Ugarte; Erwin G Zoetendal; Jun Wang; Francisco Guarner; Oluf Pedersen; Willem M de Vos; Søren Brunak; Joel Doré; María Antolín; François Artiguenave; Hervé M Blottiere; Mathieu Almeida; Christian Brechot; Carlos Cara; Christian Chervaux; Antonella Cultrone; Christine Delorme; Gérard Denariaz; Rozenn Dervyn; Konrad U Foerstner; Carsten Friss; Maarten van de Guchte; Eric Guedon; Florence Haimet; Wolfgang Huber; Johan van Hylckama-Vlieg; Alexandre Jamet; Catherine Juste; Ghalia Kaci; Jan Knol; Omar Lakhdari; Severine Layec; Karine Le Roux; Emmanuelle Maguin; Alexandre Mérieux; Raquel Melo Minardi; Christine M'rini; Jean Muller; Raish Oozeer; Julian Parkhill; Pierre Renault; Maria Rescigno; Nicolas Sanchez; Shinichi Sunagawa; Antonio Torrejon; Keith Turner; Gaetana Vandemeulebrouck; Encarna Varela; Yohanan Winogradsky; Georg Zeller; Jean Weissenbach; S Dusko Ehrlich; Peer Bork
Journal:  Nature       Date:  2011-04-20       Impact factor: 49.962

7.  The gastrointestinal microbiota affects the selenium status and selenoprotein expression in mice.

Authors:  Juliane Hrdina; Antje Banning; Anna Kipp; Gunnar Loh; Michael Blaut; Regina Brigelius-Flohé
Journal:  J Nutr Biochem       Date:  2008-09-30       Impact factor: 6.048

8.  Environmental triggers of autoimmune thyroiditis.

Authors:  C Lynne Burek; Monica V Talor
Journal:  J Autoimmun       Date:  2009-10-09       Impact factor: 7.094

9.  Steady state organ distribution and metabolism of thyroxine and 3,5,3'-triiodothyronine in intestines, liver, kidneys, blood, and residual carcass of the rat in vivo.

Authors:  T T Nguyen; J J DiStefano; H Yamada; Y M Yen
Journal:  Endocrinology       Date:  1993-12       Impact factor: 4.736

10.  B cell-deficient NOD.H-2h4 mice have CD4+CD25+ T regulatory cells that inhibit the development of spontaneous autoimmune thyroiditis.

Authors:  Shiguang Yu; Prasanta K Maiti; Melissa Dyson; Renu Jain; Helen Braley-Mullen
Journal:  J Exp Med       Date:  2006-01-30       Impact factor: 14.307

View more
  21 in total

Review 1.  Novel thyroxine formulations: a further step toward precision medicine.

Authors:  Camilla Virili; Pierpaolo Trimboli; Marco Centanni
Journal:  Endocrine       Date:  2019-10-15       Impact factor: 3.633

Review 2.  The role of the gut-brain axis in depression: endocrine, neural, and immune pathways.

Authors:  Anastasios P Makris; Minois Karianaki; Konstantinos I Tsamis; Stavroula A Paschou
Journal:  Hormones (Athens)       Date:  2020-08-21       Impact factor: 2.885

3.  Comparative assessment of gut microbial composition and function in patients with Graves' disease and Graves' orbitopathy.

Authors:  T-T Shi; Z Xin; L Hua; H Wang; R-X Zhao; Y-L Yang; R-R Xie; H-Y Liu; J-K Yang
Journal:  J Endocrinol Invest       Date:  2020-05-24       Impact factor: 4.256

4.  The comparison of microbial communities in thyroid tissues from thyroid carcinoma patients.

Authors:  Chen-Jian Liu; Si-Qian Chen; Si-Yao Zhang; Jia-Lun Wang; Xiao-Dan Tang; Kun-Xian Yang; Xiao-Ran Li
Journal:  J Microbiol       Date:  2021-10-06       Impact factor: 3.422

5.  SERUM ZONULIN LEVELS IN HYPOTHYROID AND EUTHYROID PATIENTS WITH HASHIMOTO'S THYROIDITIS - A PILOT STUDY.

Authors:  D G Tomov; B A Levterova; V N Mihaylova; D M Troev; M Z Miteva; M M Orbetzova
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Oct-Dec       Impact factor: 1.104

Review 6.  Oxidative stress in Hashimoto's thyroiditis: possible adjuvant therapies to attenuate deleterious effects.

Authors:  Gilnei Bruno da Silva; Milena Ayumi Yamauchi; Margarete Dulce Bagatini
Journal:  Mol Cell Biochem       Date:  2022-09-27       Impact factor: 3.842

Review 7.  Thyroid hormone therapy for hypothyroidism.

Authors:  Bernadette Biondi; David S Cooper
Journal:  Endocrine       Date:  2019-08-01       Impact factor: 3.633

Review 8.  Gut microbiota and Hashimoto's thyroiditis.

Authors:  Camilla Virili; Poupak Fallahi; Alessandro Antonelli; Salvatore Benvenga; Marco Centanni
Journal:  Rev Endocr Metab Disord       Date:  2018-12       Impact factor: 6.514

9.  Levothyroxine Therapy: Changes of TSH Levels by Switching Patients from Tablet to Liquid Formulation. A Systematic Review and Meta-Analysis.

Authors:  Camilla Virili; Luca Giovanella; Poupak Fallahi; Alessandro Antonelli; Maria Giulia Santaguida; Marco Centanni; Pierpaolo Trimboli
Journal:  Front Endocrinol (Lausanne)       Date:  2018-01-26       Impact factor: 5.555

Review 10.  Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report.

Authors:  M Centanni; S Benvenga; I Sachmechi
Journal:  J Endocrinol Invest       Date:  2017-07-10       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.